NEW YORK (GenomeWeb) – Danaher today initiated guidance for adjusted diluted EPS for Fiscal Year 2016 in the range of $4.80 to $4.95.

The firm assumed core revenue growth between 2 percent and 3 percent for FY 2016.

The company also reaffirmed adjusted diluted EPS for the fourth quarter of 2015 to be in the range of $1.25 to $1.29. The average Wall Street estimate is for EPS of $1.25 in Q4.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.